These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34394068)

  • 1. The Immune Heterogeneity Between Pulmonary Adenocarcinoma and Squamous Cell Carcinoma: A Comprehensive Analysis Based on lncRNA Model.
    Yan T; Ma G; Wang K; Liu W; Zhong W; Du J
    Front Immunol; 2021; 12():547333. PubMed ID: 34394068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
    Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
    J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
    Liu B; Chen Y; Yang J
    Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma.
    Theelen WSME; Krijgsman O; Monkhorst K; Kuilman T; Peters DDGC; Cornelissen S; Ligtenberg MA; Willems SM; Blaauwgeers JLG; van Noesel CJM; Peeper DS; van den Heuvel MM; Schulze K
    J Transl Med; 2020 Jul; 18(1):271. PubMed ID: 32620126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer.
    Sun J; Zhang Z; Bao S; Yan C; Hou P; Wu N; Su J; Xu L; Zhou M
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32041817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.
    Huang G; Huang Q; Xie Z; Zhou H; Cao J; Shi L; Yang M
    Cancer Biomark; 2019; 26(3):239-247. PubMed ID: 31524143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA SNHG1 regulates zinc finger E-box binding homeobox 1 expression by interacting with TAp63 and promotes cell metastasis and invasion in Lung squamous cell carcinoma.
    Zhang HY; Yang W; Zheng FS; Wang YB; Lu JB
    Biomed Pharmacother; 2017 Jun; 90():650-658. PubMed ID: 28415044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel long noncoding RNA LINC01133 is upregulated in lung squamous cell cancer and predicts survival.
    Zhang J; Zhu N; Chen X
    Tumour Biol; 2015 Sep; 36(10):7465-71. PubMed ID: 25908174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of long non-coding RNA signatures for squamous cell carcinomas and adenocarcinomas.
    Tian S; Tang M; Li J; Wang C; Liu W
    Aging (Albany NY); 2020 Dec; 13(2):2459-2479. PubMed ID: 33318305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
    Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
    Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma.
    Tian Y; Yu M; Sun L; Liu L; Wang J; Hui K; Nan Q; Nie X; Ren Y; Ren X
    J Comput Biol; 2020 Jul; 27(7):1067-1078. PubMed ID: 31750732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer.
    Sepesi B; Nelson DB; Mitchell KG; Gibbons DL; Heymach JV; Vaporciyan AA; Swisher SG; Roszik J
    Ann Thorac Surg; 2018 Jun; 105(6):1621-1626. PubMed ID: 29510096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
    Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
    Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of LINC02310 as an enhancer in lung adenocarcinoma and investigation of its regulatory network via comprehensive analyses.
    Zhao W; Wang J; Luo Q; Peng W; Li B; Wang L; Zhang C; Duan C
    BMC Med Genomics; 2020 Dec; 13(1):185. PubMed ID: 33308216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential protein-coding gene and long noncoding RNA expression in smoking-related lung squamous cell carcinoma.
    Li S; Sun X; Miao S; Liu J; Jiao W
    Thorac Cancer; 2017 Nov; 8(6):672-681. PubMed ID: 28949095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma.
    Qu Y; Cheng B; Shao N; Jia Y; Song Q; Tan B; Wang J
    Aging (Albany NY); 2020 Mar; 12(6):4757-4777. PubMed ID: 32209727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.
    Chen RL; Zhou JX; Cao Y; Sun LL; Su S; Deng XJ; Lin JT; Xiao ZW; Chen ZZ; Wang SY; Lin LZ
    Front Immunol; 2020; 11():1933. PubMed ID: 33072067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of long non-coding RNA expression reveals novel mediators of the lung tumour immune response.
    Sage AP; Ng KW; Marshall EA; Stewart GL; Minatel BC; Enfield KSS; Martin SD; Brown CJ; Abraham N; Lam WL
    Sci Rep; 2020 Oct; 10(1):16945. PubMed ID: 33037279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.